CRIF1-CDK2インターフェース阻害剤:細胞の放射線感受性の調節のための前例のない戦略
Qian Ran1, Yang Xiang1, Preyesh Stephen2
1Department of Blood Transfusion, Irradiation Biology Laboratory , Xinqiao Hospital , Chongqing , 400037 , China.
Journal of the American Chemical Society
|January 18, 2019
まとめ
CRIF1- CDK2の相互作用を標的とする新薬候補は,骨肉腫細胞の増殖を選択的に抑制し,放射線感受性を高めます. このアプローチは,がん治療のサイクリン依存キナーゼ (CDK) 標的化における選択性の問題を克服します.
科学分野:
- 腫瘍学
- 分子生物学
- 薬物の発見
背景:
- サイクリン依存キナーゼ (CDK) は細胞循環の重要な調節体であり,がんの標的として確立されています.
- CDK阻害剤はしばしば選択性の課題に直面し,治療の失敗につながります.
- CR6相互作用因子1 (CRIF1) は,CDK2との相互作用によって細胞サイクルを否定的に調節する.
研究 の 目的:
- CRIF1-CDK2の相互作用インターフェースをターゲットとする新しい小分子を特定する.
- これらの阻害剤の有効性と選択性を骨肉腫 (OS) モデルで評価する.
- これらの阻害剤がOS細胞の放射線感受性を高める可能性を評価する.
主な方法:
- CRIF1-CDK2の相互作用インターフェースのシリコ識別.
- CRIF1に対する大規模な複合図書館の仮想スクリーニング
- OS細胞系と骨髄幹細胞 (BMSC) を用いた細胞増殖測定法
- 結合性研究とG2/M停止とアポトーシス誘導の評価
- イオン化放射線 (IR) による併用治療の評価
主要な成果:
- 4つの化合物は,BMSCに影響を与えることなく,OS細胞の増殖を選択的に抑制しました.
- これらの阻害剤は,CRIF1に対する有意な結合親和性を示した.
- IRと阻害剤を併用した治療は,腫瘍増殖抑制を有意に増加させました (19. 9%から59. 6%).
- 抑制剤は,CDK2過剰活性化とリン酸化変化に関連して,OS細胞におけるG2/ M停止とアポトーシスを促進した.
- CRIF1のノックダウンは インターフェース阻害剤の効果を模倣した
結論:
- CRIF1- CDK2の相互作用を標的とする新しい鉛分子が特定されました.
- これらの化合物は,がん治療におけるCDK標的化に選択的なアプローチを提供します.
- 特定された阻害剤は骨肉腫細胞の放射線感受性を高め,新しい治療戦略を提示します.
関連する概念動画
Protein-protein Interfaces
14.7K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.7K
Protein-Protein Interfaces
4.5K
4.5K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Persuasion Strategies
43.5K
Researchers have tested many persuasion strategies, including the foot-in-the door and the door-in-the-face techniques, in a variety of contexts. Ultimately, the principles are effective in selling products and changing people’s attitude, ideas, and behaviors (Cialdini & Goldstein, 2004).
43.5K
Coping Strategies: Problem Focused
504
Coping strategies are methods people use to manage, tolerate, or reduce the effects of stressors. These strategies involve both behavioral and psychological actions to handle stressful situations. One common approach is problem-focused coping, which aims to change or eliminate the source of stress rather than merely addressing its consequences. This method involves taking direct action to resolve the issue causing stress.
For example, consider a student who struggles to understand their...
For example, consider a student who struggles to understand their...
504
Dipeptidyl Peptidase 4 Inhibitors
667
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
667


